1. 393Vancomycin Dosing in Obese Patients. (December 2014) Authors: Alquwaizani, Mohammed; Kubiak, David W.; Sansonetti, David; Barra, Megan; Calderwood, Michael S. Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An Evaluation of Systemic Vancomycin Dosing in Obese Patients. (13th November 2015) Authors: Kubiak, David W.; Alquwaizani, Mohammed; Sansonetti, David; Barra, Megan E.; Calderwood, Michael S. Journal: Open forum infectious diseases Issue: Volume 2:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center. (September 2015) Authors: Marquis, Kathleen A.; DeGrado, Jeremy R.; Labonville, Stephanie; Kubiak, David W.; Szumita, Paul M. Journal: Annals of pharmacotherapy Issue: Volume 49:Number 9(2015:Sep.) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. False positive bronchoalveolar lavage galactomannan: Effect of host and cut‐off value. Issue 3 (25th November 2018) Authors: Farmakiotis, Dimitrios; Le, Audrey; Weiss, Zoe; Ismail, Nour; Kubiak, David W.; Koo, Sophia Journal: Mycoses Issue: Volume 62:Issue 3(2019) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Implementation of a Prolonged Infusion Guideline for Time-Dependent Antimicrobial Agents at a Tertiary Academic Medical Center. (November 2016) Authors: Hohlfelder, Benjamin; Kubiak, David W.; Degrado, Jeremy R.; Reardon, David P.; Szumita, Paul M. Journal: American journal of therapeutics Issue: Volume 23:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib. Issue 2 (28th January 2019) Authors: Cummins, Kaelyn C.; Cheng, Matthew P.; Kubiak, David W.; Davids, Matthew S.; Marty, Francisco M.; Issa, Nicolas C. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 2(2019) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. (29th April 2019) Authors: Caroff, Daniel A.; Menchaca, John T.; Zhang, Zilu; Rhee, Chanu; Calderwood, Michael S.; Kubiak, David W.; Yokoe, Deborah S.; Klompas, Michael Journal: Infection control and hospital epidemiology Issue: Volume 40:Number 6(2019) Page Start: 662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacodynamic target attainment with high-dose extended-interval tobramycin therapy in patients with cystic fibrosis. (April 2014) Authors: DeGrado, Jeremy R.; Cios, Deborah; Greenwood, Bonnie C.; Kubiak, David W.; Szumita, Paul M. Journal: Journal of chemotherapy Issue: Volume 26:Number 2(2014:Apr.) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis. (29th October 2015) Authors: Johnson, Jennifer A.; Feeney, Eoin R.; Kubiak, David W.; Corey, G. Ralph Journal: Open forum infectious diseases Issue: Volume 2:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗